Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111663) titled 'An Observational Study of Individuals With Isolated Dystonia' on Aug. 1.
Study Type: Observational
Primary Sponsor: Vima Therapeutics
Condition:
Isolated/Primary Dystonia That Affects More Than One Region of the Body
Recruitment Status: Recruiting
Date of First Enrollment: June 17, 2025
Target Sample Size: 200
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07111663
Published by HT Digital Content Services with permission from Health Daily Digest....